This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Decentralized Clinical Trials
Hybrid Event | June 6 - 8, 2022
In-Person Event: June 6 - 8, Hyatt Regency Coral Gables, Miami, FloridaDigital Experience: Live-streamed keynotes on June 6 - 8 + 10 days on-demand access to all presentation recordings from June 14th

Kendal Whitlock
Formerly at Boehringer Ingelheim GmbH & Co KG, USA, Co-Leader at Decentralized Trials Research Alliance (DTRA) 3C Decentralized Research Curriculum, USA


Kendal K. Whitlock leads Healthcare Provider (HCP) network growth, change management/community engagement, and education for digital trials at Boehringer Ingelheim (BI). In this role, she developed the global HCP engagement strategy, and liaises with all other clinical trial enabling functions to establish a customized investigator network.

Kendal holds an MPH from Columbia University, and is currently working toward her doctorate. She values patient empowerment, health equity and the ethics of tech design. She is the Chair of the Product Development and Clinical Research for the Med Tech Color Collaborative Community and the Co-Lead for the Decentralized Trials Research Alliance (DTRA).

Agenda Sessions

  • How Digital is “Schooling” Pharma and Challenging Assumptions about Participation in Decentralized Clinical Trials

  • PANEL: Decentralized Trials – Solves Problems but Creates New Ones?